AEPCX | HNCJX | AEPCX / HNCJX | |
Total Expense Ratio | 1.59 | 0.98 | 162% |
Annual Report Gross Expense Ratio | 1.59 | 1.00 | 159% |
Fund Existence | 24 years | 19 years | - |
Gain YTD | 7.141 | 7.533 | 95% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 2000 | 13% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 132B | 315M | 41,905% |
Annual Yield % from dividends | 0.34 | 0.36 | 95% |
Returns for 1 year | -1.20 | 6.99 | -17% |
Returns for 3 years | 12.24 | 29.19 | 42% |
Returns for 5 years | 15.56 | 32.60 | 48% |
Returns for 10 years | 19.59 | 54.44 | 36% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SUICX | 55.50 | 0.41 | +0.74% |
DWS CROCI International C | |||
RYMKX | 50.21 | 0.31 | +0.62% |
Rydex Russell 2000 1.5x Strategy H | |||
FSSZX | 34.81 | 0.07 | +0.20% |
Fidelity Advisor Stock Selector Sm Cp Z | |||
BUIMX | 16.14 | 0.03 | +0.19% |
Buffalo Mid Cap Growth Inst | |||
FPHAX | 27.55 | -0.32 | -1.15% |
Fidelity Select Pharmaceuticals Port |